127 related articles for article (PubMed ID: 12381481)
41. Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.
Felix AS; Gaudet MM; La Vecchia C; Nagle CM; Shu XO; Weiderpass E; Adami HO; Beresford S; Bernstein L; Chen C; Cook LS; De Vivo I; Doherty JA; Friedenreich CM; Gapstur SM; Hill D; Horn-Ross PL; Lacey JV; Levi F; Liang X; Lu L; Magliocco A; McCann SE; Negri E; Olson SH; Palmer JR; Patel AV; Petruzella S; Prescott J; Risch HA; Rosenberg L; Sherman ME; Spurdle AB; Webb PM; Wise LA; Xiang YB; Xu W; Yang HP; Yu H; Zeleniuch-Jacquotte A; Brinton LA
Int J Cancer; 2015 Mar; 136(5):E410-22. PubMed ID: 25242594
[TBL] [Abstract][Full Text] [Related]
42. Abnormal pattern of integrin expression at the implantation window in endometrium from fertile women treated with clomiphene citrate and users of intrauterine device.
Gonzalez RR; Palomino A; Vantman D; Gabler F; Devoto L
Early Pregnancy (Cherry Hill); 2001 Apr; 5(2):132-43. PubMed ID: 11753526
[TBL] [Abstract][Full Text] [Related]
43. [Effectiveness of intrauterine contraceptives: the side effects and complications from their use].
Novilov IuI; Kononova ES
Akush Ginekol (Mosk); 1979 Jul; (7):46-7. PubMed ID: 484804
[TBL] [Abstract][Full Text] [Related]
44. Postovulatory endometrial development in women with I.U.D.
Nicolaisen HH; Pedersen H; Guttorm E; Rebbe H
Acta Obstet Gynecol Scand; 1973; 52(3):253-8. PubMed ID: 4126520
[TBL] [Abstract][Full Text] [Related]
45. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
[TBL] [Abstract][Full Text] [Related]
46. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
[TBL] [Abstract][Full Text] [Related]
47. [Effects of long-term installation of intrauterine devices on intrauterine microenvironment].
Dong BH; Hou GH; Zhang YZ; Fan J; Zhang P; Li L; Luo X
Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):823-6. PubMed ID: 12895331
[TBL] [Abstract][Full Text] [Related]
48. [Surgical hysteroscopy in preventing the occurrence of Asherman's syndrome following the removal of intrauterine contraceptive devices].
Davydov SN; Klimenko SA; Orlov VM
Akush Ginekol (Mosk); 1988 Aug; (8):70-1. PubMed ID: 3195716
[TBL] [Abstract][Full Text] [Related]
49. [The cytology of endometrial cavity with retained IUD (author's transl)].
Zhou SW
Zhonghua Fu Chan Ke Za Zhi; 1980 Jul; 15(3):165-8. PubMed ID: 7472015
[TBL] [Abstract][Full Text] [Related]
50. Adenocarcinoma of the endometrium following prolonged use of an intrauterine device.
Tsukahara Y; Fukamatsu Y; Hirabayashi T; Iinuma H; Fukuta T
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):339-43. PubMed ID: 6833818
[TBL] [Abstract][Full Text] [Related]
51. Pseudo-sulfur granules associated with intrauterine contraceptive devices.
O'Brien PK; Roth-Moyo LA; Davis BA
Am J Clin Pathol; 1981 Jun; 75(6):822-5. PubMed ID: 7020400
[TBL] [Abstract][Full Text] [Related]
52. [Evaluation of the cancer risk of intrauterine contraception based on cytological studies of the endometrium].
Petrov IuA
Vopr Onkol; 1985; 31(12):53-6. PubMed ID: 4082508
[TBL] [Abstract][Full Text] [Related]
53. Intrauterine devices and pelvic inflammatory disease: an international perspective.
Farley TM; Rosenberg MJ; Rowe PJ; Chen JH; Meirik O
Lancet; 1992 Mar; 339(8796):785-8. PubMed ID: 1347812
[TBL] [Abstract][Full Text] [Related]
54. Endometrial reaction with long use of intrauterine contraceptive devices (7-9 years).
Hefnawi F; Askalani AH; Hasseeb F; Issa A
Egypt Popul Fam Plann Rev; 1974 Jun; 7(1):1-10. PubMed ID: 12257563
[TBL] [Abstract][Full Text] [Related]
55. Tubal sterilization and the risk of endometrial cancer.
Castellsague X; Thompson WD; Dubrow R
Int J Cancer; 1996 Mar; 65(5):607-12. PubMed ID: 8598311
[TBL] [Abstract][Full Text] [Related]
56. Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer.
Cholakian D; Hacker K; Fader AN; Gehrig PA; Tanner EJ
Gynecol Oncol; 2016 Feb; 140(2):234-8. PubMed ID: 26706662
[TBL] [Abstract][Full Text] [Related]
57. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
58. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
59. [Endometrial cytology of IUD smears: endometrial reaction study].
Salome N; Rezende CD; Peixoto RM; Rocha AH
J Bras Ginecol; 1986; 96(6):263-6. PubMed ID: 12268684
[TBL] [Abstract][Full Text] [Related]
60. Risk factors among young women with endometrial cancer: a Danish case-control study.
Parslov M; Lidegaard O; Klintorp S; Pedersen B; Jønsson L; Eriksen PS; Ottesen B
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):23-9. PubMed ID: 10649152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
